I hear what you are saying...and feel just as conflicted about RVX these days, as you are.

What I do want to do is break down the issues. 

First, we are dealing with an immediate need for capital at RVX.  This is the only reason why we are down at $1.19 and not significantly higher.  I think it won't take much to get us out of this crunch, if just a few million warrants get converted to cash.  Immediate going concern issues resolved, RVX and us investors can then focus on next steps.

Second, we will get an FDA letter any day now.  If there is a buyer showing up, this should be the last box they are waiting to tick.  But the FDA letter will definitely bolster confidence inside the company...as we will confirmation of the path forward...whatever it is.

Third, the key question in my mind is: partner or buyout.  And this is where I am concerned...that we are headed down the partnership path, which we all agree is very sub optimal...for all involved: investors, scientists at RVX, society at large.  Don is now talking more and more about partnerships...which suggests to me that no buyer has shown any interest.  At least so far.

Finally, note that biotech company share prices do not behave like regular operating companies.  Biotech share prices suddenly take off on no news.  Only later do people figure out what happened.  I feel like RVX may be at a similar fork in the road.  Sentiment has been destroyed by the share price...but it is really the urgent need for capital that is dominating sentiment.  

Here's to hoping for the best!

Iconoclast